Skip to main content

Advertisement

Table 2 Intra- and peri-operative parameters

From: Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience

Anaesthesia time; minutes 715 (370–1135)
Additional thoracic epidural anaesthesia 45
Advanced hemodynamic monitoring  
  PiCCO 48
  Pulmonary artery catheter 3
  Both 1
Anaesthesia maintenance  
  Propofol 37
  Sevoflurane 17
  Desflurane 3
Cumulative fentanyl dose; mg 1.2 (0.2-4.0)
Effective operation time; minutes 550 (255–995)
  Length of CRS; minutes 340 (95–790)
  Length of HIPEC, minutes 90 (60–115)
  Length of reconstruction; minutes 119 (40–237)
Intraperitoneal chemotherapy (mg m−2)  
  Doxorubicin and mitomycin (15 and 15) 49
  Doxorubicin and cisplatin (15 and 50) 6
  Cisplatin and mitomycin (17 and 10)1 2
Transfer to ICU 53
Length of ICU stay; days 2 (1–35)
Postoperative ventilation 33
Length of postoperative ventilation; hours2 4 (1–10)
Hospital stay; days 17 (9–259)
  1. Data presented as median (range) or numbers (n).
  2. CRS, Cytoreductive surgery; HIPEC, hyperthermic intraperitoneal chemotherapy.
  3. Hemodynamic monitoring: PiCCO (Pulsion Medical Systems, Munich, Germany); Pulmonary artery catheter (Swan-Ganz CCOmbo, Edwards Life Sciences, Unterschleissheim, Germany).
  4. 1Reduced dose of cisplatin was given in n = 2 patients.
  5. 2Data missing in n = 6 patients.